Figures & data
Table 1 Participant characteristics (n = 411)
Table 2 Classification of MRPs (n = 795) by community pharmacists
Table 3 Comparison of trial pharmacists and independent pharmacist rating of MRP severity
Table 4 Pharmacists’ recommendations (n = 833) for 625 MRPs documented in IMeRSe feasibility study
Table 5 Pharmacists’ recommendations (n = 278) for 170 MRPs documented in PharMIbridge RCT
jppp_a_12370188_sm0001.pdf
Download PDF (303.5 KB)Availability of data and materials
The datasets generated and analysed for this study are not publicly available as consent from participants was not sought to share the data more widely than for the purpose of this study. Data are not publicly available as consent for data sharing was not obtained from participants.